HEADER DE NOVO PROTEIN 11-MAY-17 5VSG TITLE FIBRILS OF THE SUPER HELICAL REPEAT PEPTIDE, SHR-FF, GROWN AT ELEVATED TITLE 2 TEMPERATURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SUPER HELICAL REPEAT PEPTIDE SHR-FF; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 4 ORGANISM_TAXID: 32630; SOURCE 5 OTHER_DETAILS: DE NOVO DESIGN KEYWDS FIBRIL, DE NOVO DESIGN, DE NOVO PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.MONDAL,M.R.SAWAYA,D.S.EISENBERG,E.GAZIT REVDAT 3 01-JAN-20 5VSG 1 REMARK REVDAT 2 10-JUL-19 5VSG 1 JRNL REVDAT 1 27-JUN-18 5VSG 0 JRNL AUTH S.MONDAL,G.JACOBY,M.R.SAWAYA,Z.A.ARNON,L.ADLER-ABRAMOVICH, JRNL AUTH 2 P.REHAK,L.VUKOVIC,L.J.W.SHIMON,P.KRAL,R.BECK,E.GAZIT JRNL TITL TRANSITION OF METASTABLE CROSS-ALPHA CRYSTALS INTO JRNL TITL 2 CROSS-BETA FIBRILS BY BETA-TURN FLIPPING. JRNL REF J.AM.CHEM.SOC. V. 141 363 2019 JRNL REFN ESSN 1520-5126 JRNL PMID 30532955 JRNL DOI 10.1021/JACS.8B10289 REMARK 2 REMARK 2 RESOLUTION. 1.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 16.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.3 REMARK 3 NUMBER OF REFLECTIONS : 1195 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.117 REMARK 3 R VALUE (WORKING SET) : 0.114 REMARK 3 FREE R VALUE : 0.134 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 12.000 REMARK 3 FREE R VALUE TEST SET COUNT : 163 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.13 REMARK 3 REFLECTION IN BIN (WORKING SET) : 50 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 53.57 REMARK 3 BIN R VALUE (WORKING SET) : 0.2020 REMARK 3 BIN FREE R VALUE SET COUNT : 10 REMARK 3 BIN FREE R VALUE : 0.2030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 53 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 2 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 8.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.19000 REMARK 3 B22 (A**2) : 0.12000 REMARK 3 B33 (A**2) : 0.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.15000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.038 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.034 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.029 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.473 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.988 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.988 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 54 ; 0.012 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 49 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 77 ; 1.827 ; 2.138 REMARK 3 BOND ANGLES OTHERS (DEGREES): 106 ; 0.680 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 6 ; 5.379 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 2 ;16.441 ;20.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 4 ;12.293 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 7 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 60 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 16 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 103 ; 0.446 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 104 ; 1.865 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : NULL REMARK 3 ION PROBE RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5VSG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-MAY-17. REMARK 100 THE DEPOSITION ID IS D_1000227908. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-MAR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 1367 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.100 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.2 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.16500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 53.5 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.30800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO PHASING REMARK 200 SOFTWARE USED: SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5% DMSO, 100 MM HEPES, PH 7.4, BATCH REMARK 280 MODE, TEMPERATURE 310K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 10.44150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -5.34300 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 1.000000 0.000000 0.000000 5.34300 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 -10.68600 REMARK 350 BIOMT2 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 5 1.000000 0.000000 0.000000 10.68600 REMARK 350 BIOMT2 5 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 5 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 AIB A 2 -130.70 46.73 REMARK 500 REMARK 500 REMARK: NULL DBREF 5VSG A 1 7 PDB 5VSG 5VSG 1 7 SEQRES 1 A 7 SER AIB PHE SER AIB PHE AIB HET AIB A 2 6 HET AIB A 5 6 HET AIB A 7 7 HETNAM AIB ALPHA-AMINOISOBUTYRIC ACID FORMUL 1 AIB 3(C4 H9 N O2) FORMUL 2 HOH *2(H2 O) LINK C SER A 1 N AIB A 2 1555 1555 1.33 LINK C AIB A 2 N PHE A 3 1555 1555 1.34 LINK C SER A 4 N AIB A 5 1555 1555 1.33 LINK C AIB A 5 N PHE A 6 1555 1555 1.33 LINK C PHE A 6 N AIB A 7 1555 1555 1.34 CRYST1 5.343 20.883 16.795 90.00 93.90 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.187161 0.000000 0.012756 0.00000 SCALE2 0.000000 0.047886 0.000000 0.00000 SCALE3 0.000000 0.000000 0.059680 0.00000 ATOM 1 N SER A 1 1.958 7.242 12.512 1.00 8.82 N ANISOU 1 N SER A 1 1064 1103 1181 -32 -168 -63 N ATOM 2 CA SER A 1 2.006 6.219 13.597 1.00 9.21 C ANISOU 2 CA SER A 1 1211 1136 1152 -27 -42 -48 C ATOM 3 C SER A 1 2.885 6.761 14.725 1.00 8.87 C ANISOU 3 C SER A 1 1195 1079 1092 -9 -50 13 C ATOM 4 O SER A 1 3.565 7.774 14.558 1.00 8.04 O ANISOU 4 O SER A 1 1125 1043 885 57 53 -18 O ATOM 5 CB SER A 1 2.563 4.887 13.072 1.00 9.66 C ANISOU 5 CB SER A 1 1305 1079 1285 -39 -69 -50 C ATOM 6 OG SER A 1 3.977 4.914 13.008 1.00 10.16 O ANISOU 6 OG SER A 1 1325 1258 1276 83 75 -84 O HETATM 7 N AIB A 2 2.893 6.078 15.869 1.00 8.16 N ANISOU 7 N AIB A 2 1035 986 1079 -16 -1 -20 N HETATM 8 CA AIB A 2 3.708 6.504 17.020 1.00 8.26 C ANISOU 8 CA AIB A 2 1107 987 1044 115 -61 9 C HETATM 9 C AIB A 2 3.539 7.999 17.272 1.00 7.66 C ANISOU 9 C AIB A 2 985 956 968 66 -13 68 C HETATM 10 O AIB A 2 2.409 8.471 17.280 1.00 7.76 O ANISOU 10 O AIB A 2 986 938 1024 84 -107 141 O HETATM 11 CB1 AIB A 2 3.250 5.787 18.277 1.00 8.20 C ANISOU 11 CB1 AIB A 2 1021 1009 1086 -18 -76 19 C HETATM 12 CB2 AIB A 2 5.138 6.074 16.753 1.00 8.34 C ANISOU 12 CB2 AIB A 2 1044 1029 1094 41 -80 53 C ATOM 13 N PHE A 3 4.630 8.761 17.425 1.00 7.41 N ANISOU 13 N PHE A 3 958 957 899 89 -22 0 N ATOM 14 CA PHE A 3 4.572 10.201 17.759 1.00 7.52 C ANISOU 14 CA PHE A 3 968 962 924 12 -15 -21 C ATOM 15 C PHE A 3 4.667 11.107 16.548 1.00 7.95 C ANISOU 15 C PHE A 3 1096 967 956 -213 28 -22 C ATOM 16 O PHE A 3 4.710 12.333 16.668 1.00 8.83 O ANISOU 16 O PHE A 3 1239 946 1166 -148 -240 17 O ATOM 17 CB PHE A 3 5.698 10.538 18.738 1.00 8.04 C ANISOU 17 CB PHE A 3 999 1082 973 -57 -15 -67 C ATOM 18 CG PHE A 3 5.658 9.687 19.951 1.00 7.82 C ANISOU 18 CG PHE A 3 953 1030 988 -145 -95 -69 C ATOM 19 CD1 PHE A 3 4.619 9.831 20.815 1.00 9.63 C ANISOU 19 CD1 PHE A 3 1233 1272 1154 214 90 3 C ATOM 20 CD2 PHE A 3 6.586 8.686 20.182 1.00 8.03 C ANISOU 20 CD2 PHE A 3 1072 1045 935 -65 -56 -120 C ATOM 21 CE1 PHE A 3 4.517 9.035 21.929 1.00 9.97 C ANISOU 21 CE1 PHE A 3 1190 1411 1187 153 -8 101 C ATOM 22 CE2 PHE A 3 6.497 7.881 21.295 1.00 9.10 C ANISOU 22 CE2 PHE A 3 1369 1041 1045 109 -29 -51 C ATOM 23 CZ PHE A 3 5.458 8.053 22.168 1.00 8.54 C ANISOU 23 CZ PHE A 3 1029 1178 1037 -54 -190 -51 C ATOM 24 N SER A 4 4.678 10.500 15.375 1.00 7.69 N ANISOU 24 N SER A 4 1045 941 934 -99 3 7 N ATOM 25 CA SER A 4 4.901 11.237 14.159 1.00 7.58 C ANISOU 25 CA SER A 4 1000 960 920 -31 -1 17 C ATOM 26 C SER A 4 3.691 11.992 13.664 1.00 7.25 C ANISOU 26 C SER A 4 1030 901 824 -46 -19 -6 C ATOM 27 O SER A 4 2.590 11.618 13.966 1.00 8.36 O ANISOU 27 O SER A 4 976 1079 1119 -39 -28 34 O ATOM 28 CB SER A 4 5.335 10.249 13.109 1.00 6.93 C ANISOU 28 CB SER A 4 780 940 912 25 49 93 C ATOM 29 OG SER A 4 6.374 9.465 13.641 1.00 7.87 O ANISOU 29 OG SER A 4 794 1100 1096 86 -31 92 O HETATM 30 N AIB A 5 3.920 13.043 12.878 1.00 7.10 N ANISOU 30 N AIB A 5 908 886 903 -58 8 9 N HETATM 31 CA AIB A 5 2.860 13.764 12.162 1.00 7.26 C ANISOU 31 CA AIB A 5 899 975 882 -21 6 -15 C HETATM 32 C AIB A 5 2.006 12.779 11.370 1.00 7.62 C ANISOU 32 C AIB A 5 974 1006 915 -96 -41 41 C HETATM 33 O AIB A 5 0.780 12.868 11.328 1.00 7.95 O ANISOU 33 O AIB A 5 993 1112 913 -32 -166 93 O HETATM 34 CB1 AIB A 5 2.056 14.573 13.162 1.00 7.20 C ANISOU 34 CB1 AIB A 5 815 913 1009 23 -38 -36 C HETATM 35 CB2 AIB A 5 3.484 14.751 11.192 1.00 7.42 C ANISOU 35 CB2 AIB A 5 879 976 962 -1 10 43 C ATOM 36 N PHE A 6 2.669 11.835 10.708 1.00 8.13 N ANISOU 36 N PHE A 6 998 1018 1070 -88 -75 -48 N ATOM 37 CA PHE A 6 2.015 10.737 9.994 1.00 7.66 C ANISOU 37 CA PHE A 6 893 1020 994 -117 -141 57 C ATOM 38 C PHE A 6 3.108 9.700 9.778 1.00 7.89 C ANISOU 38 C PHE A 6 1022 1092 884 -47 -142 -29 C ATOM 39 O PHE A 6 4.272 10.028 9.963 1.00 8.00 O ANISOU 39 O PHE A 6 965 1013 1058 25 -45 -114 O ATOM 40 CB PHE A 6 1.390 11.217 8.673 1.00 7.89 C ANISOU 40 CB PHE A 6 1036 1008 952 -18 -90 56 C ATOM 41 CG PHE A 6 2.340 11.957 7.810 1.00 8.43 C ANISOU 41 CG PHE A 6 1020 1099 1081 -85 -27 -2 C ATOM 42 CD1 PHE A 6 3.029 11.299 6.820 1.00 10.53 C ANISOU 42 CD1 PHE A 6 1546 1153 1299 81 109 -103 C ATOM 43 CD2 PHE A 6 2.583 13.306 8.016 1.00 8.97 C ANISOU 43 CD2 PHE A 6 1273 1034 1099 50 -62 47 C ATOM 44 CE1 PHE A 6 3.934 11.976 6.037 1.00 11.90 C ANISOU 44 CE1 PHE A 6 1882 1206 1432 4 272 -40 C ATOM 45 CE2 PHE A 6 3.492 13.980 7.237 1.00 9.56 C ANISOU 45 CE2 PHE A 6 1234 1163 1232 -17 -43 42 C ATOM 46 CZ PHE A 6 4.166 13.315 6.244 1.00 10.33 C ANISOU 46 CZ PHE A 6 1247 1210 1464 -10 106 15 C HETATM 47 N AIB A 7 2.733 8.462 9.447 1.00 7.63 N ANISOU 47 N AIB A 7 986 1068 842 -4 -173 -15 N HETATM 48 CA AIB A 7 3.697 7.381 9.174 1.00 7.99 C ANISOU 48 CA AIB A 7 956 1049 1029 -76 -54 -103 C HETATM 49 C AIB A 7 4.664 7.158 10.320 1.00 9.25 C ANISOU 49 C AIB A 7 1170 1200 1143 129 -153 -53 C HETATM 50 O AIB A 7 5.855 7.005 10.140 1.00 9.48 O ANISOU 50 O AIB A 7 1202 985 1414 99 -25 166 O HETATM 51 OXT AIB A 7 4.280 7.099 11.486 1.00 9.53 O ANISOU 51 OXT AIB A 7 1213 1262 1145 19 -130 -46 O HETATM 52 CB1 AIB A 7 2.965 6.061 8.914 1.00 8.35 C ANISOU 52 CB1 AIB A 7 958 1094 1118 -89 -98 -138 C HETATM 53 CB2 AIB A 7 4.423 7.750 7.901 1.00 8.10 C ANISOU 53 CB2 AIB A 7 990 1103 985 -25 -105 -27 C TER 54 AIB A 7 HETATM 55 O HOH A 101 1.741 3.551 16.047 1.00 13.42 O ANISOU 55 O HOH A 101 1818 1074 2205 -76 -150 -52 O HETATM 56 O HOH A 102 3.395 13.194 18.990 1.00 12.04 O ANISOU 56 O HOH A 102 1161 1343 2071 -97 -570 -32 O CONECT 3 7 CONECT 7 3 8 CONECT 8 7 9 11 12 CONECT 9 8 10 13 CONECT 10 9 CONECT 11 8 CONECT 12 8 CONECT 13 9 CONECT 26 30 CONECT 30 26 31 CONECT 31 30 32 34 35 CONECT 32 31 33 36 CONECT 33 32 CONECT 34 31 CONECT 35 31 CONECT 36 32 CONECT 38 47 CONECT 47 38 48 CONECT 48 47 49 52 53 CONECT 49 48 50 51 CONECT 50 49 CONECT 51 49 CONECT 52 48 CONECT 53 48 MASTER 256 0 3 0 0 0 0 6 55 1 24 1 END